STYRAX PHARMA PRIVATE LIMITED – FDA Inspection, Nov 9, 2018

Record Details

This FDA Inspection record concerns STYRAX PHARMA PRIVATE LIMITED, with an inspection on November 9, 2018, issued by the Office of Inspections and Investigations, covering human drugs.

Company: STYRAX PHARMA PRIVATE LIMITED
Inspection Date: November 9, 2018
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Rajiv R. Srivastava (FDA Associated Person)

View Company Profile

ID · 9f36acfe-1f3f-430b-ab91-f78daf27213f

Inspection Facts

Inspection number: 1071264
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore STYRAX PHARMA PRIVATE LIMITED

FDA Inspection

STYRAX PHARMA PRIVATE LIMITEDNovember 9, 2018

STYRAX PHARMA PRIVATE LIMITED – FDA Inspection, Nov 9, 2018

Record Details

This FDA Inspection record concerns STYRAX PHARMA PRIVATE LIMITED, with an inspection on November 9, 2018, issued by the Office of Inspections and Investigations, covering human drugs.